Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UVA critical wavelength method inadequate to predict potential UVA absorption -- L'Oreal.

This article was originally published in The Tan Sheet

Executive Summary

CRITICAL WAVELENGTH TEST INADEQUATE TO DETERMINE UVA EFFICACY, L'OREAL maintains in May 15 comments to FDA on the OTC sunscreen tentative final monograph. Following a study evaluation of the proposed in vitro critical wavelength testing method, L'Oreal says it found the test "does not provide a quantitative measure of the UVA protection afforded" by an OTC sunscreen. "Since this method does not account for any biological response, it cannot adequately predict a product's protection against UVA effects on the skin," the company asserts. L'Oreal is working on an alternative testing method to measure UVA protection in sunscreens.
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088520

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel